Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox announces CE Marking of its Sexually Transmitted Infection (STI) Multiplex Array

Published: Wednesday, November 28, 2012
Last Updated: Wednesday, November 28, 2012
Bookmark and Share
Randox is pleased to announce the CE marking of the STI Multiplex Array, recognising its use as a powerful diagnostic weapon in the battle to control sexually transmitted infections.

Sexually transmitted infections (STIs) are on the increase worldwide and present a major challenge to world public health.  This rise in STI cases shows that current measures, including existing technologies and screening programmes cannot cope with clinical need. STIs are of significant medical, social and economic importance affecting up to 25-30% of young adults, with the developing world having a disproportionate burden of disease. STIs can be difficult to diagnose because of atypical or asymptomatic presentation and left untreated can result in serious health problems including infertility or complications during pregnancy.  Those with untreated STIs can also act as reservoirs for future infection.

To avoid preventable health complications and to encourage more responsible sexual health practices, Randox has developed the STI Multiplex Array that can simultaneously detect 10 of the most prevalent STIs from a single urine or swab sample, in a single test within 5 hours. These STIs include Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis, Treponema pallidum (syphilis), Herpes simplex 1 & 2, Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Haemophilus ducreyi.

STI-Multiplex-Array.gif


In addition to providing the most comprehensive STI screen available, testing for multiple STI pathogens can identify secondary infections, which are present in greater numbers than previously thought, and allow specific treatments for all infections diagnosed.  The accuracy and comprehensive diagnostic ability of the Randox STI Multiplex Array compensates for many of the current diagnosing limitations and has the potential to revolutionise STI diagnosis. This will improve patient outcome and reduce the social and economical burden of such pathogens. Using this test has added benefits through more appropriate use of antibiotics, which will reduce the potential for antibiotic resistance.

The CE marking of the STI Multiplex Array signifies that this groundbreaking test is suitable for the accurate diagnosis of STIs in a clinical setting and provides further evidence that Randox continues to develop innovative diagnostic solutions to meet the increasing demands of healthcare providers worldwide.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!